CD70 (human)-muCD8 Fusion Protein

Ancell
Product Code: ANC-537-020
Product Group: Recombinant Proteins
Supplier: Ancell
CodeSizePrice
ANC-537-020-25ug25 ug£473.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Hamster
Regulatory Status: RUO
Target Species: Human
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Flow Cytometry
Shipping:
BI
Storage:
+4°C

Further Information

EClass:
32160000
Form (Short):
liquid
Formulation:
50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 0.5% Gentamicin sulfate
Handling Advice:
Avoid freeze/thaw cycles.
Long Description:
Protein. Liquid. 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 0.5% Gentamicin sulfate Human CD70 is not present on resting lymphocytes. CD70 is expressed after activation on about 20% of T cells and on about 70% of B cells. CD70 is a ligand for CD27 and it is also a member of the TNF gene family.
Package Type:
Plastic Vial
Product Description:
Human CD70 is not present on resting lymphocytes. CD70 is expressed after activation on about 20% of T cells and on about 70% of B cells. CD70 is a ligand for CD27 and it is also a member of the TNF gene family.
Source / Host:
CHO cells
Transportation:
Non-hazardous
UNSPSC Category:
Other Proteins
UNSPSC Number:
12352202
Use & Stability:
Stable for at least 6 months after receipt when stored at -80°C. Use within 2 weeks of receipt. For extended storage, aliquot and freeze at -80°C in original buffer.

Related Products

Product NameProduct CodeSupplier 
anti-CD70 (human), mAb (BU69)ANC-222-020Ancell Summary Details
anti-CD70 (human), mAb (BU69) (Biotin)ANC-222-030Ancell Summary Details
anti-CD70 (human), mAb (BU69) (FITC)ANC-222-040Ancell Summary Details
anti-CD70 (human), mAb (BU69) (R-PE)ANC-222-050Ancell Summary Details
anti-CD70 (human), mAb (BU69) (preservative free)ANC-222-820Ancell Summary Details
CD70 (human)-muCD8 Fusion Protein (Biotin)ANC-537-030Ancell Summary Details
CD70 (human)-muCD8 Fusion Protein (preservative free)ANC-537-820Ancell Summary Details